Proteomic analysis of enriched lysosomes at early phase of camptothecin-induced apoptosis in human U-937 cells

Journal of Proteomics

Volumn 72, Issue 6, 2009, Pages 960-973

  Parent, Nicolas ^a   Winstall, Eric ^b   Beauchemin, Myriam ^a   Paquet, Claudie ^a   Poirier, Guy G ^b   Bertrand, Richard ^a,c  

^a NOTRE DAME HOSPITAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Apoptosis; Camptothecin; Confocal Microscopy; iTRAQ reagent; LC ESI MS MS; Lysosome

Indexed keywords

CAMPTOTHECIN; CASPASE; CATHEPSIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN; LYSOSOME ENZYME; PROSAPOSIN; PROTEIN KINASE C DELTA; STEROL 4 ALPHA CARBOXYLATE 3 DEHYDROGENASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL STRAIN U937; CONFOCAL MICROSCOPY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVATION; FLUORESCENCE MICROSCOPY; HISTIOCYTIC LYMPHOMA; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; LYSOSOME MEMBRANE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CAMPTOTHECIN; CARBOXY-LYASES; DNA FRAGMENTATION; HUMANS; LYSOSOMES; MEMBRANE POTENTIALS; MITOCHONDRIA; PROTEIN KINASE C-DELTA; PROTEOME; PROTEOMICS; SAPOSINS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; U937 CELLS;

EID: 67749123975     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2009.04.003     Document Type: Article

References (78)

1. Brunk U.T., Neuzil J., and Eaton J.W. Lysosomal involvement in apoptosis. Redox Rep 6 (2001) 91-97
2. Turk B., Stoka V., Rozman-Pungercar J., Cirman T., Droga-Mazovec G., Oreic K., et al. Apoptotic pathways: involvement of lysosomal proteases. Biol Chem 383 (2002) 1035-1044
3. Guicciardi M.E., Leist M., and Gores G.J. Lysosomes in cell death. Oncogene 23 (2004) 2881-2890
4. Terman A., Kurz T., Gustafsson B., and Brunk U.T. Lysosomal labilization. IUBMB Life 58 (2006) 531-539
5. Brunk U.T., and Svensson I. Oxidative stress, growth factor starvation and Fas activation may all cause apoptosis through lysosoma leak. Redox Rep 4 (1999) 3-11
6. Brunk U.T., Dalen H., Roberg K., and Hellquist H.B. Photo-oxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts. Free Radic Biol Med 23 (1997) 616-626
7. Boya P., Andreau K., Poncet D., Zamzami N., Perfettini J.L., Metivier D., et al. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med 197 (2003) 1323-1334
8. Guicciardi M.E., Deussing J., Miyoshi H., Bronk S.F., Svingen P.A., Peters C., et al. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 106 (2000) 1127-1137
9. Kagedal K., Zhao M., Svensson I., and Brunk U.T. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem J 359 (2001) 335-343
10. Heinrich M., Wickel M., Schneider-Brachert W., Sandberg C., Gahr J., Schwandner R., et al. Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J 18 (1999) 5252-5263
11. Hishita T., Tada-Oikawa T., Tohyama K., Miura Y., Nishihara T., Tohyama Y., et al. Caspase-3 activation by lysosomal enzymes in cytochrome c-independent apoptosis in myelodysplastic syndrome-derived cell line P39. Cancer Res 61 (2001) 2878-2884
12. Paquet C., Beauchemin M., and Bertrand R. Caspase- and mitochondrial dysfunction-dependent mechanisms of lysosomal leakage and cathepsin B activation in DNA damage-induced apoptosis. Leukemia 19 (2005) 784-791
13. Broker L.E., Huisman C., Span S.W., Rodriguez J.A., Kruyt F.A., and Giaccone G. Cathepsin B mediates caspase-independent cell death induced by microtubule stabilizing agents in non-small cell lung cancer cells. Cancer Res 64 (2004) 27-30
14. Kluck R.M., Martin S.J., Hoffman B.M., Zhou J.S., Green D.R., and Newmeyer D.D. Cytochrome C activation of Cpp32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO J 16 (1997) 4639-4649
15. Marzo I., Brenner C., Zamzami N., Jurgensmeier J.M., Susin S.A., Vieira H.L.A., et al. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281 (1998) 2027-2031
16. Matsuyama S., Xu Q.L., Velours J., and Reed J.C. The mitochondrial F0F1-ATPase proton pump is required for function of the proapoptotic protein Bax in yeast and mammalian cells. Mol Cell 1 (1998) 327-336
17. Shimizu S., Narita M., and Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399 (1999) 483-487
18. Vander Heiden M.G., Chandel N.S., Williamson E.K., Schumacker P.T., and Thompson C.B. Bcl-X(L) regulates the membrane potential and volume homeostasis of mitochondria. Cell 91 (1997) 627-637
19. Vander Heiden M.G., and Thompson C.B. Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis?. Nat Cell Biol 1 (1999) E209-E216
20. Kroemer G., Galluzzi L., and Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 87 (2007) 99-163
21. Reed J.C. Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ 13 (2006) 1378-1386
22. Adams J.M., and Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26 (2007) 1324-1337
23. Chittenden T., Flemington C., Houghton A.B., Ebb R.G., Gallo G.J., Elangovan B., et al. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J 14 (1995) 5589-5596
24. Polster B.M., Kinnally K.W., and Fiskum G. BH3 death domain peptide induces cell type-selective mitochondrial outer membrane permeability. J Biol Chem 276 (2001) 37887-37894
25. Chittenden T. BH3 domains: intracellular death-ligands critical for initiating apoptosis. Cancer Cell 2 (2002) 165-166
26. Kuwana T., Bouchier-Hayes L., Chipuk J.E., Bonzon C., Sullivan B.A., Green D.R., et al. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 17 (2005) 525-535
27. Kim H., Rafiuddin-Shah M., Tu H.C., Jeffers J.R., Zambetti G.P., Hsieh J.J., et al. Hierarchical regulation of mitochondrion-dependent apoptosis by Bcl-2 subfamilies. Nat Cell Biol 8 (2006) 1348-1358
28. Chen L., Willis S.N., Wei A., Smith B.J., Fletcher J.I., Hinds M.G., et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17 (2005) 393-403
29. Willis S.N., Chen L., Dewson G., Wei A., Naik E., Fletcher J.I., et al. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19 (2005) 1294-1305
30. Willis S.N., Fletcher J.I., Kaufmann T., van Delft M.F., Chen L., Czabotar P.E., et al. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315 (2007) 856-859
31. Hu J.S., Li Y.B., Wang J.W., Sun L., and Zhang G.J. Mechanism of lysophosphatidylcholine-induced lysosome destabilization. J Membr Biol 215 (2007) 27-35
32. Zhao M., Brunk U.T., and Eaton J.W. Delayed oxidant-induced cell death involves activation of phospholipase A2. FEBS Lett 509 (2001) 399-404
33. Hiraoka M., Abe A., Lu Y., Yang K., Han X., Gross R.W., et al. Lysosomal phospholipase A2 and phospholipidosis. Mol Cell Biol 26 (2006) 6139-6148
34. Wang X., Wang L.L., and Zhang G.J. Guanosine 5′-[gamma-thio]triphosphate-mediated activation of cytosol phospholipase C caused lysosomal destabilization. J Membr Biol 211 (2006) 55-63
35. Wang X., Zhao H.F., and Zhang G.J. Mechanism of cytosol phospholipase C and sphingomyelinase-induced lysosome destabilization. Biochimie 88 (2006) 913-922
36. Zhao H.F., Wang X., and Zhang G.J. Lysosome destabilization by cytosolic extracts, putative involvement of Ca(2+)/phospholipase C. FEBS Lett 579 (2005) 1551-1556
37. Chen W., Li N., Chen T., Han Y., Li C., Wang Y., et al. The lysosome-associated apoptosis-inducing protein containing the pleckstrin homology (PH) and FYVE domains (LAPF), representative of a novel family of PH and FYVE domain-containing proteins, induces caspase-independent apoptosis via the lysosomal-mitochondrial pathway. J Biol Chem 280 (2005) 40985-40995
38. Salvioli S., Ardizzoni A., Franceschi C., and Cossarizza A. Jc-1, but not Dioc(6)(3) or rhodamine 123, is a reliable fluorescent probe to assess Delta-Psi changes in intact cells; Implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 411 (1997) 77-82
39. Bertrand R., Sarang M., Jenkin J., Kerrigan D., and Pommier Y. Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Res 51 (1991) 6280-6285
40. Storrie B., and Madden E.A. Isolation of subcellular organelles. Methods Enzymol 182 (1990) 203-225
41. Paquet C., Schmitt E., Beauchemin M., and Bertrand R. Activation of multidomain and BH3-only pro-apoptotic Bcl-2 family members in p53-defective cells. Apoptosis 9 (2004) 815-831
42. Shilov I.V., Seymour S.L., Patel A.A., Loboda A., Tang W.H., Keating S.P., et al. The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics 6 (2007) 1638-1655
43. Schmitt E., Cimoli G., Steyaert A., and Bertrand R. Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities. Exp Cell Res 240 (1998) 107-121
44. Sané A.T., and Bertrand R. Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities. Cancer Res 58 (1998) 3066-3072
45. Hu Z.Z., Valencia J.C., Huang H., Chi A., Shabanowitz J., Hearing V.J., et al. Comparative bioinformatics analyses and profiling of lysosome-related organelle proteomes. Int J Mass Spectrom 259 (2007) 147-160
46. Casey T.M., Meade J.L., and Hewitt E.W. Organelle proteomics: identification of the exocytic machinery associated with the natural killer cell secretory lysosome. Mol Cell Proteomics 6 (2007) 767-780
47. Callahan J.W., Bagshaw R.D., and Mahuran D.J. The integral membrane of lysosomes: its proteins and their roles in disease. J Proteomics 72 (2009) 23-33
48. Yu Y., Wang L.S., Shen S.M., Xia L., Zhang L., Zhu Y.S., et al. Subcellular proteome analysis of camptothecin analogue NSC606985-treated acute myeloid leukemic cells. J Proteome Res 6 (2007) 3808-3818
49. Takamori S., Holt M., Stenius K., Lemke E.A., Gronborg M., Riedel D., et al. Molecular anatomy of a trafficking organelle. Cell 127 (2006) 831-846
50. Caldas H., and Herman G.E. NSDHL, an enzyme involved in cholesterol biosynthesis, traffics through the Golgi and accumulates on ER membranes and on the surface of lipid droplets. Hum Mol Genet 12 (2003) 2981-2991
51. Haucke V., and DiPaolo G. Lipids and lipid modifications in the regulation of membrane traffic. Curr Opin Cell Biol 19 (2007) 426-435
52. Kolter T., and Sandhoff K. Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. Annu Rev Cell Dev Biol 21 (2005) 81-103
53. Beltroy E.P., Liu B., Dietschy J.M., and Turley S.D. Lysosomal unesterified cholesterol content correlates with liver cell death in murine Niemann-Pick type C disease. J Lipid Res 48 (2007) 869-881
54. Bi X., and Liao G. Autophagic-lysosomal dysfunction and neurodegeneration in Niemann-Pick Type C mice: lipid starvation or indigestion?. Autophagy 3 (2007) 646-648
55. Liao G., Yao Y., Liu J., Yu Z., Cheung S., Xie A., et al. Cholesterol accumulation is associated with lysosomal dysfunction and autophagic stress in Npc1 -/- mouse brain. Am J Pathol 171 (2007) 962-975
56. Pacheco C.D., and Lieberman A.P. Lipid trafficking defects increase Beclin-1 and activate autophagy in Niemann-Pick type C disease. Autophagy 3 (2007) 487-489
57. Yuan X.M., Li W., Brunk U.T., Dalen H., Chang Y.H., and Sevanian A. Lysosomal destabilization during macrophage damage induced by cholesterol oxidation products. Free Radic Biol Med 28 (2000) 208-218
58. Koh C.H., and Cheung N.S. Cellular mechanism of U18666A-mediated apoptosis in cultured murine cortical neurons: bridging Niemann-Pick disease type C and Alzheimer's disease. Cell Signal 18 (2006) 1844-1853
59. Koh C.H., Qi R.Z., Qu D., Melendez A., Manikandan J., Bay B.H., et al. U18666A-mediated apoptosis in cultured murine cortical neurons: role of caspases, calpains and kinases. Cell Signal 18 (2006) 1572-1583
60. Lucken-Ardjomande S., Montessuit S., and Martinou J.C. Bax activation and stress-induced apoptosis delayed by the accumulation of cholesterol in mitochondrial membranes. Cell Death Differ 15 (2008) 484-493
61. Brodie C., and Blumberg P.M. Regulation of cell apoptosis by protein kinase C delta. Apoptosis 8 (2003) 19-27
62. Basu A. Involvement of protein kinase C delta in DNA damage-induced apoptosis. J Cell Mol Med 7 (2003) 341-350
63. Blass M., Kronfeld I., Kazimirsky G., Blumberg P.M., and Brodie C. Tyrosine phosphorylation of protein kinase C delta is essential for its apoptotic effect in response to etoposide. Mol Cell Biol 22 (2002) 182-195
64. Yoshida K. PKC delta signaling: mechanisms of DNA damage response and apoptosis. Cell Signal 9 (2007) 892-901
65. Gomel R., Xiang C., Finniss S., Lee H.K., Lu W., Okhrimenko H., et al. The localization of protein kinase C delta in different subcellular sites affects its proapoptotic and antiapoptotic functions and the activation of distinct downstream signaling pathways. Mol Cancer Res 5 (2007) 627-639
66. Zeidan Y.H., and Hannun Y.A. Activation of acid sphingomyelinase by protein kinase C delta-mediated phosphorylation. J Biol Chem 282 (2007) 11549-11561
67. Zeidan Y.H., Wu B.X., Jenkins R.W., Obeid L.M., and Hannun Y.A. A novel role for protein kinase C delta-mediated phosphorylation of acid sphingomyelinase in UV light-induced mitochondrial injury. FASEB J 22 (2008) 183-193
68. Chow W. Membrane targeting by C1 and C2 domains. J Biol Chem 276 (2001) 32407-32410
69. Zhang G., Kazanietz M.G., Blumberg P.M., and Hurley J.H. Crystal structure of the Cys2 activator-binding domain of protein kinase Cδ in complex with phorbol esters. Cell 81 (1995) 917-924
70. Wang Q.J., Bhattacharyya D., Garfield S., Nacro K., Marquez V.E., and Blumberg P.M. Differential localization of protein kinase C delta by phorbol esters and related compounds using a fusion protein with green fluorescent protein. J Biol Chem 274 (1999) 37233-37239
71. Siskind L.J. Mitochondrial ceramide and the induction of apoptosis. J Bioenerg Biomembr 37 (2005) 143-153
72. Khwaja A., and Tatton L. Caspase-mediated proteolysis and activation of protein kinase Cdelta plays a central role in neutrophil apoptosis. Blood 94 (1999) 291-301
73. Shin S.Y., Kim C.G., Ko J., Min D.S., Chang J.S., Ohba M., et al. Transcriptional and post-transcriptional regulation of the PKC delta gene by etoposide in L1210 murine leukemia cells: implication of PKC delta autoregulation. J Mol Biol 340 (2004) 681-693
74. Song M.G., Gao S.M., Du K.M., Xu M., Yu Y., Zhou Y.H., et al. Nanomolar concentration of NSC606985, a camptothecin analog, induces leukemic-cell apoptosis through protein kinase Cdelta-dependent mechanisms. Blood 105 (2005) 3714-3721
75. Linke T., Wilkening G., Lansmann S., Moczall H., Bartelsen O., Weisgerber J., et al. Stimulation of acid sphingomyelinase activity by lysosomal lipids and sphingolipid activator proteins. Biol Chem 382 (2001) 283-290
76. Ferlinz K., Linke T., Bartelsen O., Weiler M., and Sandhoff K. Stimulation of lysosomal sphingomyelin degradation by sphingolipid activator proteins. Chem Phys Lipids 102 (1999) 35-43
77. Terrinoni A., Ranalli M., Cadot B., Leta A., Bagetta G., Vousden K.H., et al. p73-alpha is capable of inducing scotin and ER stress. Oncogene 23 (2004) 3721-3725
78. Moenner M., Pluquet O., Bouchecareilh M., and Chevet E. Integrated endoplasmic reticulum stress responses in cancer. Cancer Res 67 (2007) 10631-10634